The North America Hyperimmune Globulin Market is supported by established healthcare infrastructure and sophisticated plasma-product manufacturing capabilities. These resources facilitate the collection, processing, and distribution of specialized antibody therapies. The Hyperimmune Globulin Market was valued at US$ 2.43 Billion in 2025 and is expected to reach US$ 4.88 Billion by 2034,...